395 related articles for article (PubMed ID: 18037290)
1. Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines.
Douty B; Wayland B; Ala PJ; Bower MJ; Pruitt J; Bostrom L; Wei M; Klabe R; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP; Yue EW
Bioorg Med Chem Lett; 2008 Jan; 18(1):66-71. PubMed ID: 18037290
[TBL] [Abstract][Full Text] [Related]
2. Isothiazolidinone heterocycles as inhibitors of protein tyrosine phosphatases: synthesis and structure-activity relationships of a peptide scaffold.
Yue EW; Wayland B; Douty B; Crawley ML; McLaughlin E; Takvorian A; Wasserman Z; Bower MJ; Wei M; Li Y; Ala PJ; Gonneville L; Wynn R; Burn TC; Liu PC; Combs AP
Bioorg Med Chem; 2006 Sep; 14(17):5833-49. PubMed ID: 16769216
[TBL] [Abstract][Full Text] [Related]
3. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
Sparks RB; Polam P; Zhu W; Crawley ML; Takvorian A; McLaughlin E; Wei M; Ala PJ; Gonneville L; Taylor N; Li Y; Wynn R; Burn TC; Liu PC; Combs AP
Bioorg Med Chem Lett; 2007 Feb; 17(3):736-40. PubMed ID: 17097290
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
[TBL] [Abstract][Full Text] [Related]
5. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
[TBL] [Abstract][Full Text] [Related]
6. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.
Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V
Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationship and docking studies of substituted aryl thiazolyl phenylsulfonamides as potential protein tyrosine phosphatase 1B inhibitors.
Varshney K; Gupta S; Rahuja N; Rawat AK; Singh N; Tamarkar AK; Srivastava AK; Saxena AK
ChemMedChem; 2012 Jul; 7(7):1185-90. PubMed ID: 22615198
[No Abstract] [Full Text] [Related]
8. Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24.
Wan ZK; Lee J; Hotchandani R; Moretto A; Binnun E; Wilson DP; Kirincich SJ; Follows BC; Ipek M; Xu W; Joseph-McCarthy D; Zhang YL; Tam M; Erbe DV; Tobin JF; Li W; Tam SY; Mansour TS; Wu J
ChemMedChem; 2008 Oct; 3(10):1525-9. PubMed ID: 18798205
[No Abstract] [Full Text] [Related]
9. Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B.
Ala PJ; Gonneville L; Hillman M; Becker-Pasha M; Yue EW; Douty B; Wayland B; Polam P; Crawley ML; McLaughlin E; Sparks RB; Glass B; Takvorian A; Combs AP; Burn TC; Hollis GF; Wynn R
J Biol Chem; 2006 Dec; 281(49):38013-21. PubMed ID: 17028182
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of protein tyrosine phosphatase-1B inhibitors.
Black E; Breed J; Breeze AL; Embrey K; Garcia R; Gero TW; Godfrey L; Kenny PW; Morley AD; Minshull CA; Pannifer AD; Read J; Rees A; Russell DJ; Toader D; Tucker J
Bioorg Med Chem Lett; 2005 May; 15(10):2503-7. PubMed ID: 15863305
[TBL] [Abstract][Full Text] [Related]
11. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
Chen YT; Tang CL; Ma WP; Gao LX; Wei Y; Zhang W; Li JY; Li J; Nan FJ
Eur J Med Chem; 2013 Nov; 69():399-412. PubMed ID: 24090912
[TBL] [Abstract][Full Text] [Related]
13. Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
Ajmani S; Karanam S; Kulkarni SA
Chem Biol Drug Des; 2009 Dec; 74(6):582-95. PubMed ID: 19824894
[TBL] [Abstract][Full Text] [Related]
14. Formylchromone derivatives as irreversible and selective inhibitors of human protein tyrosine phosphatase 1B. Kinetic and modeling studies.
Shim YS; Kim KC; Lee KA; Shrestha S; Lee KH; Kim CK; Cho H
Bioorg Med Chem; 2005 Feb; 13(4):1325-32. PubMed ID: 15670940
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
Qiu WW; Shen Q; Yang F; Wang B; Zou H; Li JY; Li J; Tang J
Bioorg Med Chem Lett; 2009 Dec; 19(23):6618-22. PubMed ID: 19846303
[TBL] [Abstract][Full Text] [Related]
16. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
17. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
18. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations.
Fang L; Zhang H; Cui W; Ji M
J Chem Inf Model; 2008 Oct; 48(10):2030-41. PubMed ID: 18831546
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
